...
首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9
【24h】

Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9

机译:六种化增强的CD20抗体在血清中介导血清中的补体依赖性细胞毒性在C9中

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We examined complement-dependent cytotoxicity (CDC) by hexamer formation-enhanced CD20 mAb Hx-7D8 of patient-derived chronic lymphocytic leukemia (CLL) cells that are relatively resistant to CDC. CDC was analyzed in normal human serum (NHS) and serum from an individual genetically deficient for C9. Hx-7D8 was able to kill up to 80% of CLL cells in complete absence of C9. We conclude that the narrow C5b-8 pores formed without C9 are sufficient for CDC due to efficient antibody-mediated hexamer formation. In the absence of C9, we observed transient intracellular increases of Ca2+ during CDC (as assessed with FLUO-4) that were extended in time. This suggests that small C5b-8 pores allow Ca2+ to enter the cell, while dissipation of the fluorescent signal accompanying cell disintegration is delayed. The Ca2+ signal is retained concomitantly with TOPRO-3 (viability dye) staining, thereby confirming that Ca2+ influx represents the most proximate mediator of cell death by CDC. (C) 2017 Elsevier Inc. All rights reserved.
机译:通过六甲醚形成增强的CD20mab HX-7d8检查患者衍生的慢性淋巴细胞白血病(CLL)细胞的补体依赖性细胞毒性(CDC),所述慢性淋巴细胞白血病(CLL)细胞对CDC相对抗性。在正常人体血清(NHS)中分析CDC,并从遗传缺乏C9的个体血清分析。 HX-7D8能够在完全没有C9的情况下杀死高达80%的CLL细胞。我们得出结论,由于有效的抗体介导的六聚体形成,没有C9形成的窄C5B-8孔足以用于CDC。在没有C9的情况下,我们观察到CDC期间CA2 +的瞬时细胞内增加(与氟-4的评估)延长。这表明小C5B-8孔允许CA2 +进入细胞,同时伴随细胞崩解的荧光信号的耗散延迟。 Ca2 +信号伴随着TOPRO-3(活力染料)染色,从而证实CA2 +涌入代表CDC细胞死亡的最近介质。 (c)2017年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号